cidrap.umn15 小时
COVID antiviral studies: Emergent resistance mutations rare, Paxlovid awareness low
A pair of new studies on COVID-19 antiviral drugs suggest that resistance mutations that emerge after treatment with ...
kpel96515 小时
Louisiana on Alert as COVID Treatment Gets Nationwide Recall
The FDA says that Gilead is reaching out to its distributors and customers by sending UPS Next Day airmail to pharmacies, ...
IFLScience on MSN18 小时
COVID-19 Virus Can Develop Drug Resistance – But Not Very Often, And Not For Long
A small study of 156 people with COVID-19 has found that mutations that confer resistance to antiviral drugs were “commonly detected”, especially in immunocompromised patients. The authors stress that ...
来自MSN19 小时
COVID-19 drugs: Are there any that work?
The first, called nirmatrelvir, blocks the activity of an enzyme the COVID-19 virus needs to copy itself, also called repl ...
infectiousdiseaseadvisor.com20 小时
Presence of Glass Particle in Veklury for Injection Vial Prompts Recall
Gilead is voluntarily recalling 1 lot of Veklury (remdesivir) for Injection 100mg/vial due to the presence of a glass particle found in a vial.